نتائج البحث - Larry Alphs

  • يعرض 1 - 13 نتائج من 13
تنقيح النتائج
  1. 1
    Treatment of Negative Symptoms

    Treatment of Negative Symptoms حسب William T. Carpenter, Douglas W Heinrichs, Larry Alphs

    منشور في 1985
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

    Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it? حسب Larry Alphs, Fabrizio Benedetti, W. Wolfgang Fleischhacker, John M. Kane

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study

    Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory a... حسب H. Lynn Starr, Jason Bermak, Lian Mao, Steve Rodriguez, Larry Alphs

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial

    Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, dou... حسب Larry Alphs, Cynthia A. Bossie, Jennifer Kern Sliwa, Yi-Wen Ma, Norris Turner

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The Challenge of Offering Long-Acting Antipsychotic Therapies

    The Challenge of Offering Long-Acting Antipsychotic Therapies حسب Peter J. Weiden, Rebecca S. Roma, Dawn I. Velligan, Larry Alphs, Matthew DiChiara, Brad Davidson

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Methodological Issues in Negative Symptom Trials

    Methodological Issues in Negative Symptom Trials حسب Stephen R. Marder, David G. Daniel, Larry Alphs, A. George Awad, Richard S.E. Keefe

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia

    Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia حسب Larry Alphs, Carmela Benson, Kimberly Cheshire-Kinney, Jean‐Pierre Lindenmayer, Lian Mao, Stephen C. Rodriguez, H. Lynn Starr

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently

    A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse freque... حسب Wayne Macfadden, Larry Alphs, J. Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia A. Bossie, Mary J. Kujawa, Ramy Mahmoud

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Genome-wide association study of paliperidone efficacy

    Genome-wide association study of paliperidone efficacy حسب Qingqin S. Li, Nathan E. Wineinger, Dong‐Jing Fu, Ondrej Libiger, Larry Alphs, Adam Savitz, Srihari Gopal, Nadine Cohen, Nicholas J. Schork

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression

    Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression حسب Ibrahim Turkoz, Larry Alphs, Jaskaran Singh, Carol Jamieson, Ella Daly, M. Shawi, John J. Sheehan, Madhukar H. Trivedi, A. John Rush

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder

    Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffe... حسب Dong‐Jing Fu, Ibrahim Turkoz, Richard Bruce Simonson, David P. Walling, Nina R. Schooler, Jean‐Pierre Lindenmayer, Carla M. Canuso, Larry Alphs

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

    Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind,... حسب Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini K. Manji, Wayne C. Drevets

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

    What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It? حسب Aaron S. Kemp, Nina R. Schooler, Amir H Kalali, Larry Alphs, R. Anand, George Awad, Michael Davidson, Sanjay Dubé, Larry Ereshefsky, Georges M. Gharabawi, Andrew C. Leon, J.P. Lépine, Steven G. Potkin, An Vermeulen

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: